Maryann Ally, MD, MPH, FACP, FHM
Article
Inebilizumab Can Treat IgG4-Related Disease
December 1, 2025
CLINICAL QUESTION: Is inebilizumab a safe and effective treatment option for IgG4-related disease? BACKGROUND: Treatment for IgG4-related disease flares currently involves glucocorticoid use and...
Article
How Should Vitamin D Levels be Interpreted in Patients with IBD?
October 1, 2025
A 35-year-old male with Crohn’s disease (CD) presents with diarrhea, frequent abdominal cramps, and fatigue. He is on a tumor necrosis factor-alpha (TNF-α) inhibitor, infliximab 5 mg/kg infusion...
Article
Little Feet in Big Halls: Experiencing the World of a HM Conference
July 1, 2025
SHM Converge 2025 was another successful meeting of the minds and gave me the opportunity to learn and network. This year was particularly special since the spring break of two of my children...
Article
Beta-Blocker Interruption or Continuation after Myocardial Infarction
May 1, 2025
Clinical question: Is the interrupted use of a beta-blocker non-inferior to its continued use in patients with a history of myocardial infarction (MI)? Background: Patients with MI are often started...